{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:01:22Z","timestamp":1782936082683,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1259,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-2314-B-075 -023 -MY2, 106-2314-B-075-005-MY2"],"award-info":[{"award-number":["MOST 104-2314-B-075 -023 -MY2, 106-2314-B-075-005-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 104-2314-B-075 -023 -MY2, 106-2314-B-075-005-MY2"],"award-info":[{"award-number":["MOST 104-2314-B-075 -023 -MY2, 106-2314-B-075-005-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41374-019-0240-y","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T14:11:00Z","timestamp":1553695860000},"page":"1203-1216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"99","author":[{"given":"Kuei-Chuan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Cheng","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Chang","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Jhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-5425","authenticated-orcid":false,"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2Suppl 1","key":"10.1038\/s41374-019-0240-y_bib1","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1038\/s41374-019-0240-y_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","article-title":"The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease","volume":"8","author":"McCullough","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1038\/s41374-019-0240-y_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.02.013","article-title":"The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease","volume":"40","author":"Caldwell","year":"2004","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-019-0240-y_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1038\/s41374-019-0240-y_bib5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMe0810291","article-title":"Weight-loss diets for the prevention and treatment of obesity","volume":"360","author":"Katan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/s41374-019-0240-y_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00001.2012","article-title":"Relaxin family peptides and their receptors","volume":"93","author":"Bathgate","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1038\/s41374-019-0240-y_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1126\/science.1065654","article-title":"Activation of orphan receptors by the hormone relaxin","volume":"295","author":"Hsu","year":"2002","journal-title":"Science"},{"key":"10.1038\/s41374-019-0240-y_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1124\/mol.105.021691","article-title":"Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms","volume":"70","author":"Halls","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1038\/s41374-019-0240-y_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.2008.03814.x","article-title":"Relaxin activates multiple cAMP signaling pathway profiles in different target cells","volume":"1160","author":"Halls","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/s41374-019-0240-y_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/mol.108.051227","article-title":"Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains","volume":"75","author":"Halls","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1038\/s41374-019-0240-y_bib11","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1074\/jbc.M114.589325","article-title":"Relaxin activates peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) through a pathway involving PPAR\u03b3 coactivator 1\u03b1 (PGC1\u03b1)","volume":"290","author":"Singh","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-019-0240-y_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.cellsig.2005.02.003","article-title":"The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells","volume":"17","author":"Delghandi","year":"2005","journal-title":"Cell Signal"},{"key":"10.1038\/s41374-019-0240-y_bib13","doi-asserted-by":"crossref","first-page":"R250","DOI":"10.1152\/ajpregu.00672.2003","article-title":"Emerging role of relaxin in renal and cardiovascular function","volume":"287","author":"Conrad","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1038\/s41374-019-0240-y_bib14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/jcb.10150","article-title":"Relaxin activates the MAP kinase pathway in human endometrial stromal cells","volume":"85","author":"Zhang","year":"2002","journal-title":"J Cell Biochem"},{"key":"10.1038\/s41374-019-0240-y_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0006-2952(03)00403-9","article-title":"Inhibition of markers of hepatic stellate cell activation by the hormone relaxin","volume":"66","author":"Bennett","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/s41374-019-0240-y_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1196\/annals.1282.027","article-title":"Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue","volume":"1041","author":"Bennett","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/s41374-019-0240-y_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.bcp.2006.12.007","article-title":"Relaxin receptors in hepatic stellate cells and cirrhotic liver","volume":"73","author":"Bennett","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/s41374-019-0240-y_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1749-6632.2008.03783.x","article-title":"Relaxin reduces fibrosis in models of progressive and established hepatic fibrosis","volume":"1160","author":"Bennett","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/s41374-019-0240-y_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.12247","article-title":"Relaxin decreases the severity of established hepatic fibrosis in mice","volume":"34","author":"Bennett","year":"2014","journal-title":"Liver Int"},{"key":"10.1038\/s41374-019-0240-y_bib20","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep.26627","article-title":"Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo","volume":"59","author":"Fallowfield","year":"2014","journal-title":"Hepatology"},{"key":"10.1038\/s41374-019-0240-y_bib21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.diabres.2007.10.017","article-title":"Plasma relaxin concentration is related to beta-cell function and insulin sensitivity in women with type 2 diabetes mellitus","volume":"79","author":"Szepietowska","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1038\/s41374-019-0240-y_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/157339912802083487","article-title":"Relaxin, insulin and diabetes: an intriguing connection","volume":"8","author":"Bani","year":"2012","journal-title":"Curr Diabetes Rev"},{"key":"10.1038\/s41374-019-0240-y_bib23","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.2337\/db13-0033","article-title":"Relaxin treatment reverses insulin resistance in mice fed a high-fat diet","volume":"62","author":"Bonner","year":"2013","journal-title":"Diabetes"},{"key":"10.1038\/s41374-019-0240-y_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1038\/s41374-019-0240-y_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10616-011-9407-0","article-title":"A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development","volume":"64","author":"Severgnini","year":"2012","journal-title":"Cytotechnology"},{"key":"10.1038\/s41374-019-0240-y_bib26","doi-asserted-by":"crossref","first-page":"E1369","DOI":"10.1073\/pnas.1202464109","article-title":"Protection from liver fibrosis by a peroxisome proliferator-activated receptor delta agonist","volume":"109","author":"Iwaisako","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41374-019-0240-y_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/gut.49.4.577","article-title":"Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo","volume":"49","author":"Williams","year":"2001","journal-title":"Gut"},{"key":"10.1038\/s41374-019-0240-y_bib28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"The NAS and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1038\/s41374-019-0240-y_bib29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1038\/s41374-019-0240-y_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ejhf.1368","article-title":"Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX\u2010AHF\u2010EU","volume":"21","author":"Maggioni","year":"2019","journal-title":"European Journal of Heart Failure"},{"key":"10.1038\/s41374-019-0240-y_bib31","doi-asserted-by":"crossref","first-page":"e1002248","DOI":"10.1371\/journal.pmed.1002248","article-title":"Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial","volume":"14","author":"Snowdon","year":"2017","journal-title":"PLoS Med"},{"key":"10.1038\/s41374-019-0240-y_bib32","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1074\/jbc.274.13.9013","article-title":"CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression","volume":"274","author":"Dell","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-019-0240-y_bib33","doi-asserted-by":"crossref","first-page":"328372","DOI":"10.1155\/2012\/328372","article-title":"The MAPK MEK1\/2-ERK1\/2 pathway and Its Implication in hepatocyte cell cycle control","volume":"2012","author":"Guegan","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1038\/s41374-019-0240-y_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0006-2952(02)01623-4","article-title":"Involvement of nitric oxide\/cyclic GMP signaling pathway in the regulation of fatty acid metabolism in rat hepatocytes","volume":"65","author":"Garcia-Villafranca","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/s41374-019-0240-y_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bcp.2014.12.004","article-title":"The liver-selective NO donor, V-PYRRO\/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet","volume":"93","author":"Maslak","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/s41374-019-0240-y_bib36","first-page":"824","article-title":"Protective effects of nitric oxide on hepatic steatosis induced by total parenteral nutrition in rats","volume":"23","author":"Zheng","year":"2002","journal-title":"Acta Pharmacol Sin"},{"key":"10.1038\/s41374-019-0240-y_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jn\/135.4.714","article-title":"Dietary l-arginine supplementation reduces fat mass in Zucker diabetic fatty rats","volume":"135","author":"Fu","year":"2005","journal-title":"J Nutr"},{"key":"10.1038\/s41374-019-0240-y_bib38","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.1079368","article-title":"Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide","volume":"299","author":"Nisoli","year":"2003","journal-title":"Science"},{"key":"10.1038\/s41374-019-0240-y_bib39","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/db11-0255","article-title":"Endothelial NO\/cGMP\/VASP signaling attenuates kupffer cell activation and hepatic insulin resistance induced by high-fat feeding","volume":"60","author":"Tateya","year":"2011","journal-title":"Diabetes"},{"key":"10.1038\/s41374-019-0240-y_bib40","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1074\/jbc.M510660200","article-title":"Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis","volume":"281","author":"Malhi","year":"2006","journal-title":"J Biol Chem"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0240-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0240-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722006985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722006985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-019-0240-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:30:38Z","timestamp":1758396638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722006985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0023683722006985"],"URL":"https:\/\/doi.org\/10.1038\/s41374-019-0240-y","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-019-0240-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}